NC
PFE icon

Nexthera Capital’s Pfizer PFE Stock Holding History

Nexthera Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-368,932
Closed -$11.8M – 44
2017
Q2 		$11.8M Sell
368,932
-458,512
-55% -$14.5M 5.12% 6
2017
Q1 		$26.9M Buy
827,444
+492,218
+147% +$15.5M 13.7% 1
2016
Q4 		$10.3M Sell
335,226
-354,144
-51% -$10.8M 6.06% 5
2016
Q3 		$22.2M Buy
689,370
+29,104
+4% +$973K 13.61% 2
2016
Q2 		$22.1M Buy
660,266
+200,722
+44% +$6.41M 19.1% 1
2016
Q1 		$12.9M Buy
459,544
+111,724
+32% +$3.19M 13.39% 3
2015
Q4 		$10.7M Buy
+347,820
New +$10.9M 15.11% 1

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nexthera Capital's PFE Position: Q3 2017 in Review

Nexthera Capital sold out of Pfizer (PFE) in Q3 2017, closing a stake of 368,932 shares — an estimated $11.8M sold.

Nexthera Capital first reported a position in PFE in Q4 2015 and held it in 7 quarters. The position peaked at $26.9M in Q1 2017. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Nexthera Capital reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • Nexthera Capital sold 368,932 Pfizer shares in Q3 2017, an estimated $11.8M.
  • Nexthera Capital first reported a position in Pfizer in Q4 2015 and held it in 7 quarters.
  • Nexthera Capital's Pfizer position peaked at $26.9M in Q1 2017.
  • 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Nexthera Capital's 13F filing for Q3 2017, filed 14 Nov 2017.